Leslie A. Miller - 27 Nov 2023 Form 3 Insider Report for Better Therapeutics, Inc.

Role
Principal Accounting Officer
Signature
/s/ Leslie A. Miller
Issuer symbol
BTTX on OTC
Transactions as of
27 Nov 2023
Net transactions value
$0
Form type
3
Filing time
07 Dec 2023, 20:09:47 UTC
Next filing
20 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BTTX Common Stock 14,350 27 Nov 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BTTX Stock Option (Right to Buy) 27 Nov 2023 Common Stock 16,100 $10.97 Direct F2
holding BTTX Stock Option (Right to Buy) 27 Nov 2023 Common Stock 11,100 $1.97 Direct F3
holding BTTX Stock Option (Right to Buy) 27 Nov 2023 Common Stock 9,650 $1.14 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares represent restricted stock units (each, an "RSU") granted on April 5, 2023, which vest as to 1/2 of the shares on March 24, 2024 and the remaining shares vest on March 24, 2025, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F2 The stock option vests as to 1/4 of the shares subject to the stock option on September 27, 2022 and the remaining shares vest in 36 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. The stock option was granted on October 28, 2021.
F3 The stock option vests as to 1/4 of the shares subject to the stock option on April 1, 2023 and the remaining shares vest in 36 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. The stock option was granted on April 1, 2022.
F4 The stock option vests as to 1/4 of the shares subject to the stock option on March 1, 2024 and the remaining shares vest in 36 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. The stock option was granted on March 1, 2023.

Remarks:

Exhibit 24 - Power of Attorney